NASDAQ:ZIMV

ZimVie (ZIMV) Stock Forecast, Price & News

$9.67

+0.08 (+0.83%)

(As of 09/22/2023 ET)

Compare

Today's Range: $9.51
▼
$9.76
50-Day Range: $9.59
▼
$14.12
52-Week Range: $5.05
▼
$15.50

Volume: 104,175 shs
Average Volume: 464,707 shs
Market Capitalization: $256.55 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $11.00

ZimVie MarketRank™ Forecast

Analyst Rating: Sell
1.00 Rating Score
Upside/Downside: 13.8% Upside
$11.00 Price Target
Short Interest: Healthy
1.97% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: 32.81%
From $0.64 to $0.85 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.57 out of 5 stars

Medical Sector

787th out of 968 stocks

Dental Equipment & Supplies Industry

4th out of 5 stocks

1.5

Analyst's Opinion

Consensus Rating
ZimVie has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no buy ratings, no hold ratings, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $11.00, ZimVie has a forecasted upside of 13.8% from its current price of $9.67.
Amount of Analyst Coverage
ZimVie has only been the subject of 1 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
1.97% of the float of ZimVie has been sold short.
Short Interest Ratio / Days to Cover
ZimVie has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in ZimVie has recently increased by 4.36%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
ZimVie does not currently pay a dividend.
Dividend Growth
ZimVie does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for ZIMV.

0.0

News and Social Media Coverage

News Coverage This Week
MarketBeat has tracked 1 news article for ZimVie this week, compared to 2 articles on an average week.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, ZimVie insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 3.01% of the stock of ZimVie is held by insiders.
Percentage Held by Institutions
85.16% of the stock of ZimVie is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for ZimVie are expected to grow by 32.81% in the coming year, from $0.64 to $0.85 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of ZimVie is -3.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of ZimVie is -3.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
ZimVie has a P/B Ratio of 0.33. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About ZimVie (NASDAQ:ZIMV) Stock

ZimVie Inc., a medical technology company, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; hardware and software solutions consist of intraoral scanners and RealGUIDE; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies. The company also provides MIS solutions, such as Vital MIS and Timberline; and motion preservation solutions, including Mobi-C and The Tether. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

ZIMV Price History

30 days | 90 days | 365 days | Advanced Chart

ZIMV Stock News Headlines

September 11, 2023 | finance.yahoo.com

Here’s Why ZimVie (ZIMV) Advanced in Q2

September 8, 2023 | fool.com

ZimVie (NASDAQ: ZIMV)

September 22, 2023 | Chaikin Analytics (Ad)

This Stock Could Go Up 66% or More.

Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023. Click here to get his latest buy. More here.

August 31, 2023 | msn.com

ZimVie (ZIMV) Price Target Increased by 57.14% to 11.22

August 17, 2023 | msn.com

ZimVie expands cooperation with Brainlab on systems compatibility, co-marketing

August 17, 2023 | finance.yahoo.com

ZimVie Expands Development Cooperation Agreement with Brainlab AG to Include Co-Marketing

August 11, 2023 | msn.com

FDA approves smaller height of Mobi-C artificial discs for cervical replacement

August 10, 2023 | msn.com

ZimVie gains on FDA nod for new Mobi-C cervical disc implant

September 22, 2023 | Chaikin Analytics (Ad)

This Stock Could Go Up 66% or More.

Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023. Click here to get his latest buy. More here.

August 10, 2023 | finance.yahoo.com

ZimVie Announces FDA Approval for New Mobi-C® Implant

August 10, 2023 | finance.yahoo.com

Why Fast-paced Mover ZimVie Inc. (ZIMV) Is a Great Choice for Value Investors

August 8, 2023 | markets.businessinsider.com

Barclays Maintains Underweight Rating for ZimVie: Here's What You Need To Know

August 6, 2023 | finance.yahoo.com

Investors in ZimVie (NASDAQ:ZIMV) have unfortunately lost 35% over the last year

August 3, 2023 | finance.yahoo.com

ZimVie Reports Second Quarter 2023 Financial Results and Provides Update to Annual Guidance

July 15, 2023 | news.yahoo.com

Hampton Roads residents come in droves for much-needed care at free pop-up clinic

July 12, 2023 | finance.yahoo.com

ZimVie to Report Second Quarter 2023 Financial Results on August 2, 2023

June 21, 2023 | msn.com

ZimVie: Downgrade To A Hold On Valuation And Fundamentals

June 2, 2023 | finance.yahoo.com

Here’s Why ZimVie (ZIMV) Declined in Q1

May 22, 2023 | finance.yahoo.com

ZimVie to Present at the Stifel 2023 Jaws & Paws Conference

May 12, 2023 | msn.com

ZimVie's Return On Capital Employed Insights

May 9, 2023 | marketwatch.com

Dental Allograft Bone Material Market Expectation Surges with Rising Demand With Top Companies | Cowellmedi, ZimVie Inc, Straumann

May 9, 2023 | msn.com

Barclays Maintains ZimVie (ZIMV) Underweight Recommendation

May 4, 2023 | benzinga.com

ZimVie shares are trading higher after the company reported better-than-expected Q1 adjusted EPS and sales results.

May 4, 2023 | finance.yahoo.com

Q1 2023 ZimVie Inc Earnings Call

May 4, 2023 | finance.yahoo.com

ZimVie (ZIMV) Q1 2023 Earnings Call Transcript

May 3, 2023 | finance.yahoo.com

ZimVie Inc. (ZIMV) Tops Q1 Earnings and Revenue Estimates

May 3, 2023 | msn.com

ZimVie Non-GAAP EPS of $0.25 beats by $0.20, revenue of $225.43M beats by $18.43M

See More Headlines

Receive ZIMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ZimVie and its competitors with MarketBeat's FREE daily newsletter.

ZIMV Company Calendar

Last Earnings: 8/02/2023
Today: 9/22/2023
Next Earnings (Estimated): 11/08/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Dental equipment & supplies
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:ZIMV
CUSIP: N/A
CIK: 1876588
Web: www.zimvie.com
Phone: 303-443-7500
Fax: N/A
Employees: 2,700
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $11.00
High Stock Price Forecast: $11.00
Low Stock Price Forecast: $11.00
Forecasted Upside/Downside: +13.8%
Consensus Rating: Sell
Rating Score (0-4): 1.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($3.16)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 15.11
P/E Growth: N/A
Net Income: $-63,880,000.00
Net Margins: -9.27%
Pretax Margin: -11.94%
Return on Equity: 3.80%
Return on Assets: 1.76%

Debt

Debt-to-Equity Ratio: 0.74
Current Ratio: 2.67
Quick Ratio: 1.47

Sales & Book Value

Annual Sales: $913.86 million
Price / Sales: 0.28
Cash Flow: $6.40 per share
Price / Cash Flow: 1.51
Book Value: $29.08 per share
Price / Book: 0.33

Miscellaneous

Outstanding Shares: 26,530,000
Free Float: 25,731,000
Market Cap: $256.55 million
Optionable: Not Optionable
Beta: 1.40

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Mr. Vafa Jamali (Age 53)
Pres, CEO & Director
Comp: $1.41M

Mr. Richard J. Heppenstall (Age 52)
Exec. VP, CFO & Treasurer
Comp: $749.83k

Mr. Indraneel Kanaglekar (Age 45)
Sr. VP & Pres of Global Dental
Comp: $534.5k

Ms. Rebecca A. Whitney (Age 46)
Sr. VP & Pres of Global Spine
Comp: $622.97k

Mr. Benjamin Hutson
Sr. VP of Operations

Sandra Schneider
Chief Accounting Officer

Mr. Steve Rondeau
Sr. VP & Chief Information Officer

Ms. Heather Kidwell (Age 54)
Sr. VP, Chief Legal, HR & Compliance Officer and Corp. Sec.

Ms. Laura Driscoll
VP of Communications

Mr. Michael Minette
Sr. VP of Strategy & Corp. Devel.

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ZIMV Stock - Frequently Asked Questions

Should I buy or sell ZimVie stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ZimVie in the last year. There are currently 1 sell rating for the stock. The consensus among Wall Street research analysts is that investors should "sell" ZIMV shares.
View ZIMV analyst ratings or view top-rated stocks.
What is ZimVie's stock price forecast for 2023?: 1 equities research analysts have issued 12 month price objectives for ZimVie's stock. Their ZIMV share price forecasts range from $11.00 to $11.00. On average, they expect the company's share price to reach $11.00 in the next twelve months. This suggests a possible upside of 13.8% from the stock's current price.
View analysts price targets for ZIMV or view top-rated stocks among Wall Street analysts.
How have ZIMV shares performed in 2023?: ZimVie's stock was trading at $9.34 at the start of the year. Since then, ZIMV shares have increased by 3.5% and is now trading at $9.67.
View the best growth stocks for 2023 here.
When is ZimVie's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023.
View our ZIMV earnings forecast.
How were ZimVie's earnings last quarter?: ZimVie Inc. (NASDAQ:ZIMV) issued its quarterly earnings data on Wednesday, August, 2nd. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.03) by $0.20. The firm had revenue of $224.90 million for the quarter, compared to analyst estimates of $212.36 million. ZimVie had a positive trailing twelve-month return on equity of 3.80% and a negative net margin of 9.27%.
What ETF holds ZimVie's stock ?: Schwab Ariel ESG ETF holds 1,617 shares of ZIMV stock, representing 0.08% of its portfolio.

What guidance has ZimVie issued on next quarter's earnings?: ZimVie issued an update on its FY 2023 earnings guidance on Thursday, August, 3rd. The company provided earnings per share guidance of $0.50-$0.70 for the period, compared to the consensus estimate of $0.46. The company issued revenue guidance of $850.00 million-$870.00 million, compared to the consensus revenue estimate of $849.00 million.
What is ZimVie's stock symbol?: ZimVie trades on the NASDAQ under the ticker symbol "ZIMV."
Who are ZimVie's major shareholders?: ZimVie's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.35%), Kent Lake Capital LLC (5.19%), Divisadero Street Capital Management LP (3.77%), Acadian Asset Management LLC (2.54%), State Street Corp (1.83%) and Charles Schwab Investment Management Inc. (1.79%). Insiders that own company stock include Richard Heppenstall, Sally Crawford and Vafa Jamali.
View institutional ownership trends.
How do I buy shares of ZimVie?: Shares of ZIMV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is ZimVie's stock price today?: One share of ZIMV stock can currently be purchased for approximately $9.67.
How much money does ZimVie make?: ZimVie (NASDAQ:ZIMV) has a market capitalization of $256.55 million and generates $913.86 million in revenue each year. The company earns $-63,880,000.00 in net income (profit) each year or ($3.16) on an earnings per share basis.
How many employees does ZimVie have?: The company employs 2,700 workers across the globe.
How can I contact ZimVie?: The official website for the company is www.zimvie.com. The company can be reached via phone at 303-443-7500 or via email at marissa@gilmartinir.com.

This page (NASDAQ:ZIMV) was last updated on 9/22/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial